An Intravenous Infusion Study of rHIgM22 in Patients With Multiple Sclerosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Enrique Carrazana, MD
Acorda Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Acorda Investigational Site
Long Beach, California, United States
- Acorda Investigational Site
Palo Alto, California, United States
- Acorda Investigational Site
Sacramento, California, United States
- Acorda Investigational Site
Stanford, California, United States
- Acorda Investigational Site
Aurora, Colorado, United States
- Acorda Investigational Site
Centennial, Colorado, United States
- Acorda Investigational Site
Indianapolis, Indiana, United States
- Acorda Investigational Site
Kansas City, Kansas, United States
- Acorda Investigational Site
Baltimore, Maryland, United States
- Acorda Investigational Site
St Louis, Missouri, United States
- Acorda Investigational Site
Rochester, New York, United States
- Acorda Investigational Site
Providence, Rhode Island, United States
- Acorda Investigational Site
Knoxville, Tennessee, United States
- Acorda Investigational Site
Dallas, Texas, United States
- Acorda Investigational Site
Burlington, Vermont, United States
- Acorda Investigational Site
Seattle, Washington, United States
- Acorda Investigational Site
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2013
- Primary completion
- 31 Oct 2014
- Completion
- 31 Jan 2015
- Last update posted
- 27 Feb 2015
- Registered enrollment
- 72
- Registry id
- NCT01803867
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.